Rating Change
JP Morgan reiterated its Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on October 07, 2026.
reiterateNASDAQ:GILD
JP Morgan Reiterates Overweight Rating on Gilead Sciences, Inc. (GILD)
JP Morgan reiterated its Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on October 07, 2026.
At publication ·
What changed
Gilead Sciences, Inc. (NASDAQ:GILD) · reiterate
- Firm
- JP Morgan
- Rating
- Overweight to Overweight
- Price at event
- $146.85
- Market capitalization
- $152.9B
At a glance
Key takeaways
- JP Morgan reiterated an Overweight rating on Gilead Sciences (GILD) on October 7, 2026.
Market Context
Gilead Sciences, Inc. operates in the Healthcare sector. The stock currently trades at $146.85 with a market capitalization of $152.9B. The stock has gained 16.2% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Gilead Sciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Gilead Sciences, Inc.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | JP Morgan | Overweight | N/A |
| Oct 07, 2026 | Truist Securities | Buy | N/A |
| Oct 07, 2026 | Morgan Stanley | Overweight | N/A |
| Sep 10, 2026 | HSBC | Buy | N/A |
| Aug 05, 2026 | RBC Capital | Sector Perform | N/A |
Related Tools: Analyst Ratings Dashboard | View GILD Stock Page
Frequently Asked Questions
What does the Overweight rating mean for GILD?
A rating of Overweight from JP Morgan reflects the analyst's outlook on Gilead Sciences, Inc. (NASDAQ:GILD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GILD forecast page.
